Edward T. Mathers

Edward T. Mathers is recorded as Board Member at MBX Biosciences, Inc. (MBX) and Board Member at OnKure Therapeutics, Inc. (OKUR) since January 1, 2017. The newest filing on record that lists Edward T. Mathers as Board Member at MBX Biosciences, Inc. (MBX) is dated April 22, 2026. The newest filing on record that lists Edward T. Mathers as Board Member at OnKure Therapeutics, Inc. (OKUR) is dated April 21, 2026. Earlier roles on record: Board Member at Rhythm Pharmaceuticals, Inc. (RYTM) until April 1, 2026. MBX Biosciences, Inc. reported in an 8-K filed June 5, 2026 that Edward T. Mathers was appointed Class II director, effective June 4, 2026. OnKure Therapeutics, Inc. reported in an 8-K filed June 4, 2026 a re-election or new board role (Class II director) for Edward T. Mathers, on the board since at least 2017, effective June 3, 2026. Rhythm Pharmaceuticals, Inc. reported in an 8-K filed April 3, 2026 that Edward T. Mathers resigned as Board, effective April 1, 2026. Equibles holds 4 filed executive changes naming Edward T. Mathers; each is listed under recent activity with its source filing. MBX Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. OnKure Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at MBX Biosciences, Inc. includes Steven Hoerter (CEO and Chairman), John Smither (CFO), Ed Mathers (Board Member) and 7 others.